Table. Recommended doses and schedules for monovalent hepatitis A vaccines | The Australian Immunisation Handbook

Date printed: 21/02/2019

Vaccine	Age of vaccine recipient (years)	Dose (hepatitis A virus antigen)	Volume per dose (mL)	No. doses	Vaccination schedule
Avaxim	≥2	160 antigen U	0.5	2	1st dose: day 0 (day of vaccination) 2nd dose: 6–36 months after 1st dose
Havrix Junior	2 to <16	720 U	0.5	2	1st dose: day 0 (day of vaccination) 2nd dose: 6–12 months after 1st dose
Havrix 1440	≥16	1440 U	1.0	2	1st dose: day 0 (day of vaccination) 2nd dose: 6–12 months after 1st dose
Vaqta Paediatric/ Adolescent	1 to <18	25 U	0.5	2	1st dose: day 0 (day of vaccination) 2nd dose: 6–18 months after 1st dose
Vaqta Adult	≥18	50 U	1.0	2	1st dose: day 0 (day of vaccination) 2nd dose: 6–18 months after 1st dose

Last updated:

1 January 2018

Last reviewed:

1 January 2018

Definitions

ELISA: enzyme-linked immunosorbent assay

Is there anything wrong with this page?

All Handbook tables

This document was printed on: 23/02/2019. Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/resources/handbook-tables/table-recommended-doses-and-schedules-for-monovalent-hepatitis-a-vaccines.